Парадокс Kenvue

Описание: Kenvue (KVUE) stock closed at $17.78 on Sept 11, 2026. The Kimberly-Clark (KMB) merger is expected to close in Q4 2026. Is KVUE a buy, sell, or hold now? In this 13-minute deep dive, we answer 100 investor questions on the KVUE-KMB merger, merger arbitrage spread, price targets, dividends, Tylenol litigation, regulatory approvals, and what it all means for investors.

We cover:

Deal terms: $3.50 cash + 0.14625 KMB shares

Implied deal value: ~$17.90

Current merger spread: ~0.63%

Analyst consensus: Hold, average target $19.30

Q2 2026 earnings: EPS $0.31, organic sales +1.6%

Regulatory status: U.S., India, Australia cleared; EU under review

Tylenol autism litigation update

KVUE dividend: $0.21 quarterly, ~4.72% yield

KMB dividend streak and balance sheet risk

Final verdict: merger arb vs long-term growth vs income

⏱️ Timestamps
0:00 Intro & Thesis
1:00 Deal Structure
2:30 Regulatory Progress
4:00 Financial Performance
5:30 KMB Exposure Risk
7:00 Legal Risks
8:30 Dividend & Income
10:00 Analyst Consensus & Valuation
11:30 Final Assessment: Is KVUE a Buy?
13:00 Disclaimer & Outro

📊 Key Data as of Sept 12, 2026

KVUE Price: $17.78

KMB Price: $98.48

Implied Deal Value: $17.90

Merger Spread: 0.63%

Consensus Rating: Hold

Avg Price Target: $19.30

FY2026E EPS: $1.18

Dividend Yield: ~4.72%

⚠️ Disclaimer: This video is for informational purposes only and is not investment advice. Verify live prices and regulatory updates before making any decisions. Consult a licensed financial advisor.

🔔 Subscribe for more stock deep dives, merger arbitrage analysis, and dividend investing breakdowns.

#KVUE #Kenvue #KenvueStock #KVUEStock #KimberlyClark #KMB #MergerArbitrage #StockMarket #Investing #DividendStocks #StockAnalysis #KVUEBuyOrSell #KenvueMerger #ConsumerStaples #StockForecast2026